Exelixis, Inc. (EXEL) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
EXEL Stock Price Trajectory (2011–2026)
As of March 2, 2026, Exelixis, Inc. (EXEL) trades at $44.06, representing a +13.9% return over the past year. The stock has delivered a +14.6% return over five years, reflecting significant long-term value creation.
The stock reached its all-time high of $999.99 on October 22, 2007. From this peak, EXEL has corrected -95.6%, currently trading 6% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers RVMD (+150.4% 1Y), INCY (+37.8% 1Y), and GMAB (+29.8% 1Y), EXEL has underperformed the peer group average. Compare EXEL vs RVMD →
Historical Price Data
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-02-27 | 43.96 | 44.87 | 43.51 | 44.06 | 44 | -0.50% |
| 2026-02-26 | 44.91 | 45.01 | 44.12 | 44.28 | 44 | -1.05% |
| 2026-02-25 | 45.43 | 45.87 | 44.74 | 44.75 | 44 | -0.86% |
| 2026-02-24 | 43.91 | 45.27 | 43.53 | 45.14 | 45 | +2.57% |
| 2026-02-23 | 43.50 | 44.49 | 43.45 | 44.01 | 44 | +0.87% |
| 2026-02-20 | 44.05 | 44.23 | 43.45 | 43.63 | 43 | -1.20% |
| 2026-02-19 | 44.15 | 44.64 | 43.75 | 44.16 | 2.66M | -0.70% |
| 2026-02-18 | 44.00 | 44.64 | 43.20 | 44.47 | 2.69M | -0.16% |
| 2026-02-17 | 43.96 | 44.67 | 43.83 | 44.54 | 157K | +1.42% |
| 2026-02-13 | 42.89 | 44.05 | 42.73 | 43.92 | 2.06M | +2.86% |
| 2026-02-12 | 42.83 | 43.52 | 42.35 | 42.70 | 2.56M | -0.56% |
| 2026-02-11 | 43.46 | 43.83 | 40.92 | 42.94 | 3.95M | -0.09% |
| 2026-02-10 | 43.97 | 44.28 | 42.93 | 42.98 | 3.25M | -2.21% |
| 2026-02-09 | 43.94 | 44.15 | 43.45 | 43.95 | 2.18M | +0.11% |
| 2026-02-06 | 42.86 | 44.20 | 42.75 | 43.90 | 3.36M | +3.61% |
| 2026-02-05 | 42.70 | 43.70 | 42.17 | 42.37 | 2.38M | -0.66% |
| 2026-02-04 | 42.79 | 43.41 | 42.22 | 42.65 | 2.61M | +0.14% |
| 2026-02-03 | 42.51 | 43.54 | 42.28 | 42.59 | 2.39M | -0.51% |
| 2026-02-02 | 42.01 | 42.83 | 40.54 | 42.81 | 4.15M | +3.51% |
| 2026-01-30 | 42.18 | 42.50 | 40.76 | 41.36 | 3.44M | -2.18% |
| 2026-01-29 | 42.63 | 43.29 | 41.90 | 42.28 | 3.12M | -0.89% |
| 2026-01-28 | 43.52 | 43.61 | 42.32 | 42.66 | 2.33M | -2.47% |
| 2026-01-27 | 43.80 | 44.85 | 43.23 | 43.74 | 1.93M | +0.30% |
| 2026-01-26 | 44.47 | 44.98 | 43.53 | 43.61 | 2.26M | -1.49% |
| 2026-01-24 | 44.64 | 45.36 | 44.12 | 44.27 | 1.98M | 0.00% |
| 2026-01-23 | 44.64 | 45.37 | 44.12 | 44.27 | 2.12M | -0.52% |
| 2026-01-22 | 45.00 | 45.04 | 44.10 | 44.50 | 2.20M | -0.69% |
| 2026-01-21 | 43.72 | 45.41 | 43.71 | 44.81 | 2.01M | +2.35% |
| 2026-01-20 | 43.14 | 44.28 | 43.00 | 43.78 | 1.66M | -0.41% |
| 2026-01-16 | 45.44 | 45.52 | 43.54 | 43.96 | 2.90M | -3.26% |
See EXEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EXEL Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare EXEL vs AGIO
See how EXEL stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
How has EXEL stock performed recently?
EXEL returned +13.9% over the past year, beating its 5-year annualized CAGR of +14.6%. The stock trades above its 200-day moving average, confirming the uptrend.
What is EXEL's all-time high price?
Exelixis, Inc. reached $999.99 on 2007-10-22. The 52-week high is $49.62. Current 1-year return of +13.9% places the stock closer to historical peaks.
Where can I download EXEL historical price data?
This page provides EXEL daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.